Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-78,909
Closed -$5.96M 611
2026
Q1
$5.96M Buy
78,909
+63,385
+408% +$4.77M 3.28% 1
2025
Q4
$1.16M Buy
15,524
+5,951
+62% +$435K 0.54% 33
2025
Q3
$646K Buy
+9,573
New +$635K 0.28% 98
2025
Q2
Sell
-6,810
Closed -$421K 508
2025
Q1
$421K Buy
+6,810
New +$451K 0.45% 66

Other funds holding HOLX

R Squared's HOLX Position: Q2 2026 in Review

R Squared sold out of Hologic (HOLX) in Q2 2026, closing a stake of 78,909 shares — an estimated $5.96M sold.

R Squared first reported a position in HOLX in Q1 2025 and held it in 4 quarters. The position peaked at $5.96M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • R Squared reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • R Squared sold 78,909 Hologic shares in Q2 2026, an estimated $5.96M.
  • R Squared first reported a position in Hologic in Q1 2025 and held it in 4 quarters.
  • R Squared's Hologic position peaked at $5.96M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.